A detailed history of Marathon Trading Investment Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Marathon Trading Investment Management LLC holds 10,617 shares of PFE stock, worth $279,864. This represents 0.15% of its overall portfolio holdings.

Number of Shares
10,617
Previous 14,971 29.08%
Holding current value
$279,864
Previous $418,000 26.56%
% of portfolio
0.15%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$27.7 - $31.39 $120,605 - $136,672
-4,354 Reduced 29.08%
10,617 $307,000
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $677,927 - $794,404
-26,838 Reduced 64.19%
14,971 $418,000
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $3.24 Million - $3.72 Million
-125,089 Reduced 74.95%
41,809 $1.16 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $2.36 Million - $3.06 Million
90,257 Added 117.77%
166,898 $4.8 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $1.9 Million - $2.22 Million
59,121 Added 337.45%
76,641 $2.54 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $202,524 - $234,316
5,607 Added 47.07%
17,520 $642,000
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $469,253 - $610,898
11,913 New
11,913 $486,000
Q4 2022

May 24, 2023

SELL
$41.75 - $54.5 $313,667 - $409,458
-7,513 Reduced 63.07%
4,400 $225,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $219,325 - $267,741
5,012 Added 113.91%
9,412 $412,000
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $201,300 - $249,436
4,400 New
4,400 $228,000
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $244,187 - $276,624
-6,800 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $170,799 - $192,627
-5,100 Reduced 42.86%
6,800 $246,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $398,293 - $506,464
11,900 New
11,900 $438,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.